Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2018 |
| Author/s |
author: Paul E. de Jong Pieternella J Lugtenburg Tim A Kanters |
| Publication date | September 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |